Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Efficacy of N-acetylcysteine (NAC) to Protect Against Hepato-renal Ischemia-reperfusion Injury in Patients Undergoing Orthotopic Liver Transplantation

NCT00736541 is registered in ClinicalTrials.gov with Ibtesam Hilmi as lead sponsor.

NCT NCT00736541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00736541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Efficacy of N-acetylcysteine (NAC) to Protect Against Hepato-renal Ischemia-reperfusion Injury in Patients Undergoing Orthotopic Liver Transplantation
Lead sponsor
Ibtesam Hilmi
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2004
Completion date
January 31, 2008
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage liver failure